CSL - Current Assets

Stock Price
145.21
Daily Change
-2.17 -1.47%
Monthly
-20.62%
Yearly
-44.68%
Q1 Forecast
150.05

CSL reported $11.85B in Current Assets for its fiscal semester ending in June of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Arca Biopharma USD 355.16M 23.15M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Bio Path USD 680K 1.44M Jun/2025
Brainstorm Cell Therapeutics USD 508K 1.01M Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
CSL USD 11.85B 542M Jun/2025
Curis USD 14.42M 10.39M Jun/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Immunic USD 39.27M 20.57M Sep/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 13.02M 2.53M Sep/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024